Influenza vaccine scarcity 2004-05: Implications for biosecurity and public health preparedness

Biosecurity and Bioterrorism

Volumn 3, Issue 3, 2005, Pages 224-234

  Schoch Spana, Monica ^a   Fitzgerald, Joseph ^a   Kramer, Bradley R ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; BIOLOGICAL WARFARE; DECISION MAKING; DISASTER PLANNING; EPIDEMIOLOGY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; LEADERSHIP; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH SERVICE; RISK MANAGEMENT; UNITED STATES; VIROLOGY;

BIOTERRORISM; CONFOUNDING FACTORS (EPIDEMIOLOGY); DECISION MAKING; DISASTER PLANNING; HEALTH PLAN IMPLEMENTATION; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEADERSHIP; PENNSYLVANIA; PUBLIC HEALTH PRACTICE; REGIONAL HEALTH PLANNING; RISK MANAGEMENT; SECURITY MEASURES;

EID: 33646459709     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2005.3.224     Document Type: Article

References (40)

1. Working Group on "Governance Dilemmas" in Bioterrorism Response. Leading during bioattacks and epidemics with the public's trust and help. Biosecur Bioterror 2004;2(1):25-40.
2. Kipnis K. Overwhelming casualties: Medical ethics in a time of terror. In: Moreno J, ed. In the Wake of Terror. Cambridge, Mass: MIT Press; 2003:95-107.
3. Childress JF. Triage in response to a bioterrorist attack. In: Moreno J, ed. In the Wake of Terror. Cambridge, Mass: MIT Press; 2003:76-93.
4. O'Toole T, Mair M, Inglesby TV. Shining light on Dark Winter. Clin Infect Dis 2002 Apr 1;34(7):972-983.
5. O'Toole T, Inglesby TV. Epidemic response scenario: decision-making in a time of plague. Public Health Rep 2001;116(Suppl 2):92-103.
6. Meltzer MI, Cox N, Fukuda K. The economic impact of influenza in the United States: priorities for intervention. Emerg Infect Dis 1999;5(5):659-671.
7. Schmidt V. Models of health care rationing. Curr Sociol 2004;52(6):969-988.
8. Mechanic D. Muddling through elegantly: finding the proper balance in rationing. Health Aff 1997;16(5):83-92.
9. Zussman R. Sociological perspectives on medical ethics and decision-making. Annu Rev Sociol 1997;(23):171-190.
10. Phelps CE. Rationing alternatives for medical care. Annu Rev Public Health 1994;15:413-436.
11. st Sess, February 10, 2005 (testimony of Jesse L. Goodman, Director of the Center for Biologics Evaluation and Research, Food and Drug Administration).
12. Lister SA, Williams ED. Influenza Vaccine Shortages and Implications. Washington, DC: Congressional Research Service; December 27, 2004. Available at: http://www. house.gov/maloney/issues/govreform/012704CRS_flu.pdf Accessed April 28, 2005.
13. Couzin J. Ethicists to guide rationing of flu vaccine. Science 2004;306:960-961.
14. Cosgrove SE, Fishman NO, Talbot TR, et al. Strategies for use of a limited influenza vaccine supply. JAMA 2005; 293(2):229-232.
15. Lee TH. Rationing influenza vaccine. N Engl J Med 2004; 351(23):2365-2366.
16. University of Pittsburgh Medical Center News Bureau. Facts and Figures. Available at: http://aboutupmc.upmc. com/Facts.htm. Accessed August 2, 2005.
17. Stein R. Flu vaccine shortage now a surplus. Washington Post 22 January 2005.
18. Mercola J. How did the flu-shot shortage become a surplus? USA Today 26 January 2005.
19. Millions gave up flu shots for sick, elderly. CNN March 22, 2005. Available at: http://www.cnn.com/2005/HEALTH/conditions/3/22/flu.vaccine.ap/ index.html. Accessed March 23, 2005.
20. Allen D, Griffiths L, Lyne P. Accommodating health and social care needs: routine resource allocation in stroke rehabilitation. Sociol Health Illn 2004;26(4):411-432.
21. Prior L. Rationing through risk assessment in clinical genetics: all categories have wheels. Sociol Health Illn 2001;23(5):570-593.
22. Lapsley I, Melia K. Clinical actions and financial constraints: the limits to rationing intensive care. Sociol Health Illn 2001;23(5):729-746.
23. Gannon J. 2004 stories of the year; ending with unanswered questions. Pittsburgh Post-Gazette 26 December 2004.
24. Tauber AI. Medicine, public health, and the ethics of rationing. Perspect Biol Med 2002;45(1):16-30.
25. Latour B. Science in Action: How to Follow Scientists and Engineers through Society. Milton Keynes, UK: Open University Press; 1987.
26. Bijker WE, Hughes TP, Pinch T, eds. The Social Construction of Technological Systems. Cambridge, Mass: MIT Press; 1989.
27. Wailoo A, Anand P. The nature of procedural preferences for health-care rationing decisions. Soc Sci Med 2005;60: 223-236.
28. Richardson J, McKie J. Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector? Soc Sci Med 2005;60:265-275.
29. Daniels N. Justice, health, and healthcare. Am J Bioeth 2001;1(2):2-16.
30. Faden RR, Kass NE. Bioethics and public health in the 1980s: resource allocation and AIDS. Annu Rev Public Health 1991;12:335-360.
31. Jecker NS, Berg AO. Allocating medical resources in rural America: alternative perceptions of justice. Soc Sci Med 1992;34(5):467-474.
32. Mossad SB. Coping with the influenza vaccine shortage. Cleve Clin J Med 2004;71(12):918-927.
33. DesRoches CM, Blendon RJ, Benson JM. Americans' responses to the 2004 influenza vaccine shortage. Health Aff 2005;24(3):822-831.
34. Clarke L. Panic: myth or reality? Contexts 2002;Fall:21-26.
35. Harper SA, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004;53(RR6):1-40.
36. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 2005;23(17-18):2251- 2255.
37. Gursky E, Inglesby TV, O'Toole T. Anthrax 2001: observations on the medical and public health response. Biosecur Bioterror 2003;1(2):97-110.
38. Blanchard JC, Haywood Y, Stein B, et al. In their own words: lessons learned from those exposed to anthrax. Am J Public Health 2005;95(3):489-495.
39. Traynor K. Vaccine shortages persist despite lessons from past. Am J Health Syst Pharm 2004:61:2458-2462.
40. Poland GA, Marcuse EK. Vaccine availability in the US: problems and solutions. Nat Immunol 2004;5(12):1195-1198.